Inhibitory activities of microalgal extracts against Epstein-Barr Virus (EBV) antigen expression in lymphoblastoid cells

The aim of this study was to identify the presence of herpes simplex virus types 1 and 2 (HSV-1, HSV-2), Varicella Zoster virus (VZV), Epstein-Barr virus (EBV), human

Epstein-Barr virus (EBV)-related post-transplant lymphoproliferative disease (PTLD) is one of the most serious complications associated with solid organ and hematopoietic stem

To find Epstein-Barr virus (EBV) strains with genetic variations of EBV latent membrane protein 1 (EBV-LMP1) from nasopharyngeal carcinoma (NPC), the full-length DNA of LMP1 genes

Subsequently, we demonstrated activity of high dose AZT in both AIDS related Epstein Barr Virus (EBV) positive Burkitt’s Lymphoma (BL) and primary central nervous system lymphoma

Abstract: The purpose of the present investigation was to compare the presence of Ep- stein-Barr virus type 1 (EBV-1) and of Human Cytomegalovirus (HCMV) in crevicu- lar

Percentage for positive samples in the period of the study for enterovirus (ENT), herpes simplex virus (HSV) human herpes virus type 6 (HHV6) Epstein Barr virus (EBV) and

Specific gene mutations in PID patients are responsible for susceptibility to Epstein---Barr virus (EBV) infections, as highlighted in the letter to the editor of the Jornal de

Evaluation of the Presence of Human Papillomavirus (HPV) and Epstein- Barr Virus (EBV) and the Expression of the Proteins p53, p16, E-cadherin, COX-2, MYC and MLH1 in Oral